 Eli Lilly  Co is making a bet on rising global demand for animal drugs and vaccines with a deal to acquire Novartis AGs animalhealth business for  billion Lilly said the purchase would make its Elanco unit the secondbiggest animalhealth company by global revenue behind Zoetis Inc the company spun out by Pfizer Inc last year Previously Lilly ranked No  and Novartis was No  This
  